Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 5 | 2023 | 658 | 1.170 |
Why?
|
| Ureaplasma Infections | 1 | 2023 | 8 | 0.840 |
Why?
|
| Agammaglobulinemia | 1 | 2023 | 41 | 0.820 |
Why?
|
| Arthritis | 1 | 2023 | 81 | 0.790 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2009 | 819 | 0.530 |
Why?
|
| Diabetic Nephropathies | 2 | 2008 | 110 | 0.500 |
Why?
|
| Albuminuria | 3 | 2009 | 103 | 0.380 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2023 | 32 | 0.330 |
Why?
|
| Kidney Diseases | 1 | 2009 | 487 | 0.240 |
Why?
|
| Ureaplasma | 1 | 2023 | 8 | 0.210 |
Why?
|
| Kidney | 2 | 2008 | 1361 | 0.190 |
Why?
|
| Rituximab | 1 | 2023 | 157 | 0.190 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 2021 | 2 | 0.190 |
Why?
|
| Aquaporin 2 | 1 | 2021 | 7 | 0.190 |
Why?
|
| Transplant Recipients | 1 | 2022 | 220 | 0.170 |
Why?
|
| Child, Hospitalized | 1 | 2019 | 74 | 0.160 |
Why?
|
| Graft Rejection | 1 | 2022 | 596 | 0.150 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 649 | 0.150 |
Why?
|
| Disease Progression | 3 | 2009 | 2105 | 0.140 |
Why?
|
| Actinin | 1 | 2016 | 5 | 0.140 |
Why?
|
| Adolescent | 7 | 2023 | 19531 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 3 | 2008 | 513 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 101 | 0.110 |
Why?
|
| Maternal Exposure | 1 | 2015 | 150 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 219 | 0.110 |
Why?
|
| Nephrology | 1 | 2015 | 148 | 0.110 |
Why?
|
| Humans | 14 | 2023 | 126366 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2015 | 375 | 0.090 |
Why?
|
| Child | 6 | 2022 | 24739 | 0.090 |
Why?
|
| Fetus | 1 | 2015 | 590 | 0.090 |
Why?
|
| Urate Oxidase | 1 | 2009 | 17 | 0.080 |
Why?
|
| Hyperuricemia | 1 | 2009 | 41 | 0.080 |
Why?
|
| Gout Suppressants | 1 | 2009 | 72 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2008 | 114 | 0.070 |
Why?
|
| Reference Values | 2 | 2008 | 722 | 0.070 |
Why?
|
| Cysteamine | 1 | 2007 | 15 | 0.070 |
Why?
|
| Radiation-Protective Agents | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cystinosis | 1 | 2007 | 16 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 741 | 0.070 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2007 | 110 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1402 | 0.060 |
Why?
|
| Female | 7 | 2023 | 67337 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2023 | 4875 | 0.060 |
Why?
|
| Biopsy | 1 | 2008 | 1257 | 0.060 |
Why?
|
| Creatinine | 2 | 2019 | 395 | 0.050 |
Why?
|
| Age of Onset | 1 | 2005 | 609 | 0.050 |
Why?
|
| Apolipoprotein L1 | 1 | 2023 | 11 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2008 | 645 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2023 | 71 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 5202 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2021 | 127 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2005 | 1357 | 0.040 |
Why?
|
| Biomarkers | 1 | 2008 | 3154 | 0.040 |
Why?
|
| Oocytes | 1 | 2021 | 298 | 0.040 |
Why?
|
| Infant | 4 | 2021 | 12667 | 0.040 |
Why?
|
| Prognosis | 1 | 2008 | 4734 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2021 | 1115 | 0.040 |
Why?
|
| Pedigree | 1 | 2021 | 1615 | 0.030 |
Why?
|
| Genotype | 1 | 2023 | 2593 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 424 | 0.030 |
Why?
|
| Male | 5 | 2021 | 62042 | 0.030 |
Why?
|
| Young Adult | 1 | 2009 | 9166 | 0.030 |
Why?
|
| Midwestern United States | 1 | 2015 | 17 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 29800 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 1973 | 0.030 |
Why?
|
| Mutation | 2 | 2021 | 5961 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 120 | 0.030 |
Why?
|
| Time Factors | 1 | 2005 | 6338 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 167 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 653 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 10377 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 540 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2015 | 16522 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2016 | 1021 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2009 | 76 | 0.020 |
Why?
|
| Urination | 1 | 2009 | 24 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8301 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2015 | 14207 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6177 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2015 | 862 | 0.020 |
Why?
|
| Minnesota | 1 | 2008 | 144 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 248 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2007 | 48 | 0.020 |
Why?
|
| Fasting | 1 | 2008 | 294 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2007 | 95 | 0.020 |
Why?
|
| Gestational Age | 1 | 2009 | 1174 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 242 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1341 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 1167 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 1253 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 343 | 0.010 |
Why?
|
| Insulin | 1 | 2008 | 1207 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 7258 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 34548 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 12386 | 0.010 |
Why?
|